ESR1 and breast carcinoma: For combined risk categories determined by the joint classification of HRT use (never, past, current) and BMI tertiles, for ER-PR- breast cancer, using never users of HRT in the lowest BMI tertile as a reference category, the highest relative risk for current HRT use was seen for women in the first BMI tertile, while relative risks were somewhat weaker for women in the middle and upper tertiles of BMI (Figure 2).